Literature DB >> 24416994

Antitumor activity and antioxidant role of Streblus asper bark against Ehrlich ascites carcinoma in Swiss albino mice.

R B Suresh Kumar1, Biswakanth Kar1, Narayan Dolai1, Indrajit Karmakar1, Sagnik Haldar1, Sanjib Bhattacharya2, Pallab K Haldar1.   

Abstract

The present study assessed the methanol extract of Streblus asper stem bark (MESA) for antitumor effect and antioxidant influence against Ehrlich ascites carcinoma (EAC) in Swiss albino mice. Twenty four hours after intraperitonial inoculation of tumor (EAC) cells in mice, MESA was administered at 200 and 400 mg/kg body weight daily for 9 consecutive days. On the 10 th day, half of the mice were sacrificed for estimation of tumor parameters, haematological, liver and kidney antioxidant parameters; and the rest were kept alive for assessment of survival. MESA exhibited dose dependent and significant (p < 0.01) decrease in tumor proliferation and extended the life span of EAC bearing mice. Hematological profiles were significantly (p < 0.01) restored near to normal in MESA treated mice as compared to EAC control. MESA treatment significantly (p < 0.01) modulated the hepatic and renal antioxidant parameters as compared to EAC control. The present study demonstrated that S. asper bark possessed promising antitumor efficacy in mice, plausibly mediated by amelioration of oxidative stress by multiple mechanisms.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24416994

Source DB:  PubMed          Journal:  J Exp Ther Oncol        ISSN: 1359-4117


  2 in total

1.  Protective Effects of Streblus asper Leaf Extract on H2O2-Induced ROS in SK-N-SH Cells and MPTP-Induced Parkinson's Disease-Like Symptoms in C57BL/6 Mouse.

Authors:  Kanathip Singsai; Tarinee Akaravichien; Veerapol Kukongviriyapan; Jintana Sattayasai
Journal:  Evid Based Complement Alternat Med       Date:  2015-12-21       Impact factor: 2.629

2.  Acid-base fractions separated from Streblus asper leaf ethanolic extract exhibited antibacterial, antioxidant, anti-acetylcholinesterase, and neuroprotective activities.

Authors:  Anchalee Prasansuklab; Atsadang Theerasri; Matthew Payne; Alison T Ung; Tewin Tencomnao
Journal:  BMC Complement Altern Med       Date:  2018-07-24       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.